The Petitions Committee schedules a debate on making Orkambi available on the NHS for people with Cystic Fibrosis after an e-petition on petition.parliament.uk collects over 114,000 signatures.
Monday 19 March 2018, Westminster Hall
The Committee has scheduled a debate in Westminster Hall on the motion "That this House has considered e-petition 209455 relating to access to the drug Orkambi for people with Cystic Fibrosis." Paul Scully MP, will open the debate.
Why is this petition being debated?
The Petitions Committee has the power to schedule debates on e-petitions in the House of Commons Second Chamber, Westminster Hall.
In deciding which petitions should be debated, it takes into account how many people have signed the petition, the topicality of the issue raised, whether the issue has recently been debated in Parliament, and the breadth of interest among MPs.
What will the petition debate achieve?
Debates on petitions in Westminster Hall are general debates about the issues raised by the petition. MPs can discuss the petition and, if they wish, ask questions about the Government’s position on the issue or press the Government to take action. A Government Minister takes part in the debate and answers the points raised.
These debates help to raise the profile of a campaign and could influence decision-making in Government and Parliament. Petition debates in Westminster Hall cannot directly change the law or result in a vote to implement the request of the petition. Creating new laws, or changing existing ones, can only be done through the parliamentary legislative process which involves a number of debates, and detailed consideration of the law in draft, in both the House of Commons and the House of Lords. This process is normally started by the Government, although there are some ways in which individual MPs or members of the House of Lords who are not in the Government (known as "backbenchers") can ask Parliament to consider new laws.